# SPRING PHARMACEUTICAL GROUP, INC.

SPRING PHARMACEUTICAL GROUP, INC. is a company headquartered in Sichui, China.

## Company overview

- **Legal name:** SPRING PHARMACEUTICAL GROUP, INC.
- **Former names in filing history:** China YCT International Group, Inc. (2008-02-14 to 2018-09-10); itLinkz Group, Inc. (2007-04-09 to 2007-11-27); MEDICAL TECHNOLOGY & INNOVATIONS INC /FL/ (1996-07-23 to 2007-03-30)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Sichui, China
- **Incorporated in:** FL
- **Fiscal year end:** March 31
- **SEC CIK:** 0000847464

## About

SPRING PHARMACEUTICAL GROUP, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000847464, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-06-29, it reported annual revenue of USD 64,942,737; net income of USD 11,738,488; total assets of USD 110,138,099 for the fiscal period ended 2018-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2017 (period ended 2018-03-31)

- **Revenue:** $64.9M (USD 64,942,737)
- **Net income:** $11.7M (USD 11,738,488)
- **Total assets:** $110.1M (USD 110,138,099)
- **Cash and equivalents:** $25.4M (USD 25,353,360)

### FY2016 (period ended 2017-03-31)

- **Revenue:** $56.5M (USD 56,463,164)
- **Net income:** $10.1M (USD 10,078,303)
- **Total assets:** $90.3M (USD 90,287,026)
- **Cash and equivalents:** $10.3M (USD 10,308,622)
- **Operating cash flow:** $9.7M (USD 9,736,074)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2016-03-31)

- **Revenue:** $47.8M (USD 47,827,108)
- **Net income:** $8.4M (USD 8,416,769)
- **Total assets:** $81.3M (USD 81,315,507)
- **Cash and equivalents:** $7.6M (USD 7,639,084)
- **Operating cash flow:** $8.6M (USD 8,553,127)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2015-03-31)

- **Revenue:** $37.9M (USD 37,943,113)
- **Net income:** $8.9M (USD 8,890,473)
- **Total assets:** $77.2M (USD 77,157,875)
- **Cash and equivalents:** $13.1M (USD 13,083,532)
- **Operating cash flow:** $11.2M (USD 11,182,527)

## Recent SEC filings

- Form 8-K — filed 2019-05-02 — period 2019-01-08 — 8K
- Form 8-K — filed 2019-02-19 — period 2019-02-14 — 8K
- Form 10-Q — filed 2019-02-14 — period 2018-12-31 — 10Q
- Form 8-K — filed 2018-11-30 — period 2018-11-27 — 8K
- Form 10-Q — filed 2018-11-13 — period 2018-09-30 — 10Q
- Form 8-K — filed 2018-10-26 — period 2018-10-17 — 8K
- Form DEF 14A — filed 2018-09-10 — period 2018-09-10 — DEF 14A
- Form 8-K — filed 2018-08-31 — period 2018-08-31 — 8K
- Form 8-K — filed 2018-08-30 — period 2018-08-30 — 8K
- Form 8-K — filed 2018-08-16 — period 2018-08-14 — 8K
- Form 10-Q — filed 2018-08-14 — period 2018-06-30 — 10Q
- Form S-1 — filed 2018-07-13 — S-1

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/spring-pharmaceutical-group-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology